RE-IMAGINE DIAGNOSTICS

Pioneering a Novel Approach to Synthetic Biology Based Assays

Along with collaborators at KU Leuven, Bloonics has developed an approach to enabling the use of laboratory grade diagnostics nearly anywhere at a fraction of the costs today. This platform technology will first be applied to uncovering physiological insights on both cannabis and the endocannabinoid system, circumventing the hurdles towards research in this field. With this, we aim to further our understanding of both the mechanisms of intoxication and immune-driven disease, forming the basis for new policy and industry collaborations.